RESEARCH TRIANGLE PARK, NC, Nov. 5, 2020 — Pappas Capital, a leading venture capital firm focused on advancing life sciences, today announced that its portfolio company, VelosBio Inc. (“VelosBio” or the...
After Change Up Top, Syntonix Inks Boehringer Ingelheim Deal Worth Up to $63M
© 2020 Pappas Capital, LLC. ALL RIGHTS RESERVED.